CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY – Get Free Report) was the target of a significant growth in short interest in October. As of October 31st, there was short interest totalling 429,500 shares, a growth of 5,949.3% from the October 15th total of 7,100 shares. Based on an average daily trading volume, of 313,200 shares, the days-to-cover ratio is currently 1.4 days.
CSPC Pharmaceutical Group Stock Down 1.7 %
Shares of OTCMKTS CSPCY opened at C$2.63 on Thursday. CSPC Pharmaceutical Group has a twelve month low of C$2.25 and a twelve month high of C$3.82. The stock has a fifty day simple moving average of C$2.87 and a 200-day simple moving average of C$3.03.
CSPC Pharmaceutical Group Increases Dividend
The company also recently disclosed a dividend, which will be paid on Thursday, December 5th. Stockholders of record on Friday, November 1st will be paid a $0.0575 dividend. The ex-dividend date is Friday, November 1st. This is a boost from CSPC Pharmaceutical Group’s previous dividend of $0.06.
About CSPC Pharmaceutical Group
CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People's Republic of China, other Asian regions, North America, Europe, and internationally. The company operates through Finished Drugs, Bulk Products, and Functional Food and Others segments.
See Also
- Five stocks we like better than CSPC Pharmaceutical Group
- Top Stocks Investing in 5G Technology
- Rocket Lab is the Right Stock for the Right Time
- 3 Grocery Stocks That Are Proving They Are Still Essential
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for CSPC Pharmaceutical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSPC Pharmaceutical Group and related companies with MarketBeat.com's FREE daily email newsletter.